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and toe systolic pressures correlate well with the
severity of the symptoms and with the angiographic
findings.3-6 Ankle and toe pressures are used as stan-
dards for classification of the severity of the arterial
disease and in the assessment for the presence of crit-
ical limb ischemia.7,8
However, arterial rigidity associated with medial
calcification may interfere with measurements of
ankle pressures. In some cases, it may be impossible
to stop the flow even with cuff pressure of 300 mm
Hg, or the pressures may be falsely exaggerated.
These phenomena were found in 17% to 24% of dia-
betic limbs and have also been reported in patients
undergoing renal dialysis after renal transplantation
and in other elderly patients.3,9,10 Also, measure-
ments of pressure at the ankle will not detect isolat-
ed obstruction in one or even two of the three
branches of the popliteal artery between the knee
and the ankle or the obstruction in the more distal
vessels in the foot itself.3,4 In contrast, toe systolic
pressures reflect the effect of the overall obstruction
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Noninvasive measurements of limb systolic pres-
sures have been applied successfully to the diagnosis
and follow-up of individual patients with peripheral
arterial disease, to the study of the natural history of
the disease, and to the evaluation of results of
surgery and of other forms of therapy.1-3 Both ankle
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in the arterial tree proximal to the measured digits
and are not thought to be affected by arterial calci-
fication.2,3,9 However, the presence of skin ulcers,
gangrene, or previous digital amputation may pre-
clude measurements of toe pressures. This has been
reported in 5% of 346 limbs in 309 patients with
skin lesions who were referred consecutively to the
vascular laboratory, including 56% with diabetes (S.
A. Carter and R. B. Tate, unpublished data, 1999),
and in 27% of 159 patients with diabetes who had
foot lesions.10
Measurement of skin perfusion pressure (SPP) is
a noninvasive test that has been shown to be useful
in the assessment of peripheral arterial disease, espe-
cially in the determination of the optimal level for
amputation, and in the assessment of critical
ischemia.11-15 Similar to the toe pressure, SPP
reflects the overall status of the more proximal arte-
rial system and is not affected by arterial wall calcifi-
cation. However, SPP can be measured in the limbs
when skin lesions on the toe or digital amputation
precludes measurement of the toe pressure. This
study was undertaken to determine whether SPP
measured in the foot was comparable to the toe
pressure and could be used in the assessment of
limbs for the severity of the obstruction and for crit-
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ical ischemia, especially in cases in which the toe and
ankle pressures cannot be determined.
METHODS
Seventy-one patients referred to the vascular lab-
oratory for evaluation of peripheral arterial disease
were studied from June 1997 to February 1998.
There were 53 men and 18 women. Their age
ranged from 33 to 89 years, with a mean age of 68
years. Forty-three patients (54 limbs) had diabetes.
Measurements were carried out in 85 limbs with the
patient in the supine position. Toe pressures were
measured with photoplethysmography.16-18 A pneu-
matic cuff was wrapped around the proximal phalanx
of the great toe, and a photoelectric probe was
placed distal to the cuff. The pneumatic cuff was
inflated to a suprasystolic pressure and then deflated
until the tracing showed deflection. The pressure at
which the deflection in the tracing occurred was
taken to be the toe systolic pressure.
The SPP was measured in the patient while in the
supine position at room temperature with a laser
Doppler probe enclosed within the bladder of the
cuff wrapped around the patient’s forefoot.15 The
pneumatic cuff was then inflated to a suprasystolic
pressure. At this pressure, the laser Doppler flux was
The relationship of toe pressure to SPP of the foot. (r = 0.87, N = 85 limbs, toe pressure = 1.20 [SPP]
–4.26).
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less than 0.1 volume percent. The cuff was deflated
stepwise in decrements of 10 mm Hg until 50 mm
Hg and then 5 mm Hg decrements below 50 mm
Hg. Pressure was held for 15 seconds at each pres-
sure interval. Deflation was continued until two
consecutive increases in laser Doppler scan flux were
noted. The first increase in laser Doppler output rep-
resents the initiation of blood flow into the regional
microcirculation and was taken to be the foot SPP.
The technique of SPP measurement has been
described previously14,15 and illustrated in
detail.19,20 The relationship of the toe pressure to
foot SPP was assessed by using linear regression and
Pearson correlation coefficients.
RESULTS
The Figure shows the relationship of the SPP to
toe systolic pressure in all limbs. The correlation
coefficient was 0.873 (P < .01). Similarly, high cor-
relation coefficients were found for the diabetic and
nondiabetic limbs (0.854 and 0.934, respectively;
both P < .01). In 72 (85%) of the 85 limbs, toe pres-
sure and SPP were both 30 mm Hg or less and more
than 30 mm Hg.
DISCUSSION
Our results show that SPP correlates closely with the
toe systolic pressure in the limbs of patients with dia-
betes and patients without diabetes. Good correlation
between toe pressure and SPP was shown previously
with the use of the radioisotope clearance technique to
measure SPP.21 The SPP measured with the laser
Doppler probe correlates well with measurements with
the use of the radioisotope technique, but it is less time-
consuming. Foot SPP can be measured in less than 5
minutes per limb with the laser Doppler method.
Ankle pressure 50 mm Hg or less and toe pres-
sure 30 mm Hg or less have been proposed as crite-
ria for the determination of critical limb ischemia.8
Although the validity of these criteria has been chal-
lenged,22,23 pressure measurements are well stan-
dardized and at this time remain the best method to
quantitate the severity of arterial disease and esti-
mate the likelihood of critical ischemia.7,8
Because ankle pressures cannot be measured in a
significant proportion of patients with diabetes or
renal failure and toe pressure cannot be measured in
patients with skin lesions on the toes or who had
previous digital amputations, measurements of SPP
are a convenient method that can be applied in such
patients and used as a substitute for toe pressure.
Furthermore, SPP can be measured on the foot in
the region where skin ulcers are often located rather
than proximally at the ankle or distally at the toe.
This might provide a better criterion for the healing
or nonhealing of such lesions. Whether or not that is
the case, outcome studies in which SPP and toe
pressure are compared will be required.
It is likely that the presence or absence of critical
ischemia depends not only on the local systolic pres-
sure but also on the events in the microcirculation
resulting from ischemia and the adequacy of perfu-
sion of the tissues in limbs with severe arterial dis-
ease.8 It has been suggested that measurements relat-
ed to tissue perfusion such as transcutaneous oxygen
pressure and digital pulsation may improve assess-
ment for critical ischemia when combined with pres-
sure measurements.7,18,24,25 Because SPP reflects
perfusion pressure in smaller vessels, it might provide
a better index of the presence or absence of critical
ischemia than ankle or toe pressures. Prospective out-
come studies are needed to assess this possibility.
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DISCUSSION
Dr Felix Tsai. I will answer the first two questions
together. Our purpose of the study was not to determine
any cutoff point in using skin profusion pressure as an indi-
cator for wound healing. However, I did reference our ear-
lier studies, and I shall give you some numbers just so you
know what to use.
In a previous study we had a total of 61 patients, half of
whom required major revascularization, half of whom were
given local wound healing. Thirty-one of the 32 patients
requiring major revascularization had skin profusion pres-
sures less that 30 mm Hg. Of the 29 patients who under-
went local wound healing, 75% of the patients who healed
had skin profusion pressures greater than 30 mm Hg.
Eighty-four percent of the patients who failed to heal
with local therapy had skin profusion pressures less than
30 mm Hg. We tend to use 30 mm Hg as our cutoff in
terms of healing, but this study was mainly used to com-
pare toe pressures and skin profusion pressure.
In regard to the third question Dr Ballard asked, if we
compared it with other testing modalities such as TCP02
or digital pulsatility, we do not have great experience with
TCP02 at our institution, so we chose not to compare it
at this time. We hope to have another prospective study
soon comparing different testing modalities in a specifical-
ly defined patient population to determine the correlation
between, for instance, toe pressure, TCP02, and skin pro-
fusion pressure.
For the fourth question, how easy is it to learn this
technique and how well do the patients tolerate the tech-
nique, when we first started doing this study I had to learn
how to do this technique from the vascular technologists,
and I got to be the guinea pig for several tests.
It takes about 5 minutes to learn. It is a handheld con-
trol to release the pressure device. So that takes a little
practice, but it is fairly easy to learn and fairly well tolerat-
ed for the most part by patients.
Dr Baker. Have you studied variability in the measure-
ments that might result from differences in skin temperature
or cigarette smoking?
Dr Tsai. There have been previous studies documenting
skin perfusion pressure reproducibility given the fact of
things like temperature, whether the patient has ingested
quantities of caffeine or alcohol or had been smoking, and
how well these correlate.
You are right. There is some change with skin profu-
sion pressure. It is not an exact test; however, repro-
ducibility appears to be pretty good in our institution.
Dr DeLaira. When this device first came out, I used it
in a study of women who were undergoing radiation for
breast cancer to see if we could follow what changes in
skin occurred using the laser Doppler. We found there was
a strong influence between the results we had and the
patient’s skin color. For fairer skinned individuals, the
device worked very well. For darker skinned individuals,
the device did not work at all.
Did you see any of that and does that influence your
results?
Dr Tsai. Unfortunately, I am not able to tell you regard-
ing the skin color of our patients. At our home institution,
for the most part, our patients are fair skinned, and so we do
not have a lot of variability in our skin profusion pressure.
Dr Andros. You told us about a technique that is proxy
for measurement of toe pressures. I am proud of our soci-
ety in that two of the people that first described toe pres-
sures as an index foot perfusion are members of this soci-
ety, Vic Bernhard and Sergio Salles-Cunha.
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Have you measured all five toes? We have measured all
five toes, and in diabetics we find quite a variation because of
changes in intrapedal circulation. We also studied ankle/arm
indices in diabetics and found that in those patients that are
compressible, there is a major variation among the dorsal
pedis, posterior tibial, and peroneal arteries. So there is a
variation in that. Did you measure only the first toe? 
My final question is, if a patient has no toes, what is the
indication for measuring perfusion of the skin of the foot?
Dr Tsai. Excellent questions. No, we did not measure all
five toes. We only measured the great toe in our patients.
In terms of comments about the ABIs in diabetics, Dr
Carter has some unpublished data that show that he
found over a quarter of his patients with diabetes had
noncompressible vessels. So we did not measure ABIs in
those patients.
In terms of patients with no toes, they still get skin
lesions of the forefoot, of the insole, and on the sole of the
foot. The indication is to determine if critical ischemia is
present and if they will need some sort of revascularization
technique or amputation. We think that skin profusion
pressure may be helpful.
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